期刊文献+

糖调节受损患者血小板活化的研究

Study on the activation of platelet in patients with impaired glucose regulation.
下载PDF
导出
摘要 目的探讨糖调节受损对血小板活化的影响,并对相关影响因素进行分析。方法将78例糖调节受损(IGR)患者分为空腹血糖受损组(IFG)、糖耐量受损组(IGT)、两者并存组(IFG+IGT),检测其血小板活化指标CD62P、CD63、CD41、CD61,并与糖化血红蛋白、血脂、尿微量白蛋白进行相关性分析。结果IFG组I、GT组I、FG+IGT组CD62P、CD63、CD41、CD61明显高于正常对照组(P<0.01)。血小板活化指标与糖化血红蛋白、尿微量白蛋白之间呈显著正相关,与胆固醇、甘油三脂、低密度脂蛋白无明显相关。结论糖调节受损患者已存在血小板活化增高,并与糖化血红蛋白、尿微量白蛋白呈正相关。 Objective To investigate the changes of platelet activation in patients with impaired glucose regulation (IGR) and relevant factors. Methods Seventy - eight IGR patients were divided into impaired fasting glucose (IFG) group, impaired glucose tolerance (IGT) and IFG + IGT group according to OGTY results. The levels of platelet CD62p, CD63, CD41 and CD61 were determined by flow eytometry. The levels of HbA1 C, blood - lipid and urinary albumin excretion rate (UAER) were also measured. Restilts The levels of platelet CD62p, CD63, CD41 and CD61 were significantly higher in IFG group, IGT group and IFG + IGT group as compared with those in control group (P 〈 0.05- 0.01 ) and the levels were positively correlated with the levels of HbAIC and UAER(HbA1C:r=0.47, r=0.43, r=0.35, r=0.39, P 〈0.05-0.01; UAER:r=0.53, r=0.51, r=0.39, r=0.41, P 〈 0.01). Conclusion The levels platelet CD62p,CD63,CD41 and CD61 in patients with IGR are increased and they are positively correlated to the levels of HbA1C and UAER.
出处 《中国热带医学》 CAS 2007年第5期691-692,共2页 China Tropical Medicine
基金 深圳市科技项目(200104058)
关键词 糖调节异常 血小板活化 糖化血红蛋白 尿微量白蛋白 Impaired glucose regulation Platelet activation HbA1 C Urinary albumin excretion rate
  • 相关文献

参考文献8

二级参考文献34

  • 1[1]Fuller JH, Shipley M J, Rose G, et al. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the whitehall study. Br Med J, 1983, 287:867-870.
  • 2[2]Strano A, Davi G, Patrono C. In vivo platelet activation in diabetes mellitus. Serm Thromb Haemost, 1991, 17: 422-430.
  • 3[3]Wang X, Wei W, Wang H. Laboratory techniques of molecular markers. In: Wang Z, Li G, Ruan C, eds. Thrombosis and haemostasis. Basic principles and clinic. Shanghai Science-technique Press, 1996, 668-673.
  • 4[4]Catella F, Healy D, Lawson JA, et al. 11-dehydro-thromboxane B2:a quantitative index of thronboxane A2 formation in the human circulation. Proc Natl Acad Sci USA, 1986, 83:5861-5865.
  • 5[5]Wang Z, Chen D, He Y, et al. 125 I-labeled radioimmunoassay for thromboxane B2. Suzhou Academia Acta, 1986, 6: 13-15.
  • 6[6]Wang Z, Wang S, Ruan C. Measurement of 11-dehydro-thromboxane B2 and its clinical significance. Chin J Haematol, 1996, 17: 472-475.
  • 7[7]Shattil SHJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood, 1987, 70: 307-314.
  • 8[8]Wu G, Ruan C. Measurement of platelet granule membrane protein using 125I-labeled monoclonal antibodies. Chin J Nucl Med, 1993, 13:46-48.
  • 9[9]Zhao Y, He Y, Shen W, et al. Plasma P-selectin measurement using the ERMA method and its clinical significance. J Exp Haematol,1997, 5: 426-428.
  • 10[10]Gresele P, Catalano M, Giammarresi C, et al. Flatelet activation markers in patients with peripheral arterial disease. Thromb Haemost, 1997, 87: 1434-1438.

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部